Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ECG NYSE:EE NASDAQ:TMDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECGEverus Construction Group$70.14-5.5%$64.25$31.38▼$77.93$3.79BN/A483,985 shs637,009 shsEEExcelerate Energy$25.55-0.4%$28.16$17.54▼$32.99$2.93B1.38452,644 shs661,462 shsTMDXTransMedics Group$120.55+1.3%$124.51$55.00▼$177.37$4.06B2.091.20 million shs1.78 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECGEverus Construction Group-5.56%-4.48%+9.51%+54.97%+7,013,999,900.00%EEExcelerate Energy-0.35%+7.13%-11.87%-0.58%+26.92%TMDXTransMedics Group+1.33%+11.50%-5.59%+33.97%-15.26%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationECGEverus Construction Group0.5575 of 5 stars1.30.00.00.02.20.01.3EEExcelerate Energy3.4866 of 5 stars3.13.01.70.03.30.02.5TMDXTransMedics Group2.4781 of 5 stars2.42.00.00.02.82.51.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECGEverus Construction Group 2.50Moderate Buy$73.675.03% UpsideEEExcelerate Energy 2.14Hold$32.2926.36% UpsideTMDXTransMedics Group 2.80Moderate Buy$129.117.10% UpsideCurrent Analyst Ratings BreakdownLatest TMDX, EE, and ECG Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/1/2025TMDXTransMedics GroupMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $123.007/18/2025ECGEverus Construction GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$66.00 ➝ $70.007/15/2025TMDXTransMedics GroupCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$129.00 ➝ $142.007/11/2025ECGEverus Construction GroupStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$71.00 ➝ $83.006/17/2025TMDXTransMedics GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$130.00 ➝ $150.006/17/2025TMDXTransMedics GroupNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold6/5/2025EEExcelerate EnergyJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$39.006/4/2025TMDXTransMedics GroupPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$125.00 ➝ $145.006/3/2025TMDXTransMedics GroupNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/16/2025ECGEverus Construction GroupStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$55.00 ➝ $71.005/15/2025ECGEverus Construction GroupDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$58.00 ➝ $68.00(Data available from 8/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECGEverus Construction Group$2.85B1.26$3.13 per share22.40$8.29 per share8.46EEExcelerate Energy$851.44M3.42$1.29 per share19.80$17.83 per share1.43TMDXTransMedics Group$441.54M9.31$1.67 per share72.31$9.33 per share12.92Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECGEverus Construction Group$143.42MN/A0.0025.32N/A4.98%33.27%11.79%8/12/2025 (Estimated)EEExcelerate Energy$32.88M$1.4717.3819.50N/A3.93%2.20%1.44%8/11/2025 (Estimated)TMDXTransMedics Group$35.46M$1.9362.4684.30N/A13.49%28.02%8.64%N/ALatest TMDX, EE, and ECG EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025ECGEverus Construction Group$0.65N/AN/AN/A$749.12 millionN/A8/11/2025Q2 2025EEExcelerate Energy$0.33N/AN/AN/A$259.82 millionN/A7/30/2025Q2 2025TMDXTransMedics Group$0.48$0.92+$0.44$0.92$146.64 million$157.37 million5/13/2025Q1 2025ECGEverus Construction Group$0.43$0.72+$0.29$0.72$676.35 million$826.63 million5/8/2025Q1 2025TMDXTransMedics Group$0.29$0.70+$0.41$0.70$123.39 million$143.54 million5/7/2025Q1 2025EEExcelerate Energy$0.39$0.49+$0.10$0.46$207.87 million$315.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthECGEverus Construction GroupN/AN/AN/AN/AN/AEEExcelerate Energy$0.240.94%N/A16.33%2 YearsTMDXTransMedics GroupN/AN/AN/AN/AN/ALatest TMDX, EE, and ECG DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/31/2025EEExcelerate Energyquarterly$0.081.25%8/20/20259/4/20255/1/2025EEExcelerate Energyquarterly$0.060.94%5/21/20255/21/20256/5/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECGEverus Construction Group0.601.781.69EEExcelerate Energy0.313.343.34TMDXTransMedics Group1.619.868.32Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECGEverus Construction GroupN/AEEExcelerate Energy21.79%TMDXTransMedics Group99.67%Insider OwnershipCompanyInsider OwnershipECGEverus Construction Group0.21%EEExcelerate Energy1.83%TMDXTransMedics Group7.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECGEverus Construction Group8,70051.00 million50.89 millionN/AEEExcelerate Energy900114.02 million111.93 millionOptionableTMDXTransMedics Group21034.09 million31.46 millionOptionableTMDX, EE, and ECG HeadlinesRecent News About These CompaniesTransMedics Group (NASDAQ:TMDX) Shares Gap Up After Earnings Beat1 hour ago | americanbankingnews.comTransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)August 1 at 4:05 PM | prnewswire.comTMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins UpAugust 1 at 1:11 PM | zacks.comTransMedics Group (NASDAQ:TMDX) Shares Gap Up Following Better-Than-Expected EarningsAugust 1 at 11:05 AM | marketbeat.comHere's Why TransMedics Group (NASDAQ:TMDX) Has Caught The Eye Of InvestorsAugust 1 at 9:23 AM | finance.yahoo.comTransMedics Group, Inc.: TransMedics Reports Second Quarter 2025 Financial ResultsAugust 1 at 9:23 AM | finanznachrichten.deTransMedics Group, Inc. (NASDAQ:TMDX) Q2 2025 Earnings Call TranscriptAugust 1 at 9:23 AM | msn.comTransMedics Group, Inc. (NASDAQ:TMDX) Shares Purchased by HB Wealth Management LLCAugust 1 at 7:09 AM | marketbeat.comTransMedics: Continued Strength Suggests Further UpsideAugust 1 at 7:03 AM | seekingalpha.comEnvestnet Asset Management Inc. Sells 61,007 Shares of TransMedics Group, Inc. (NASDAQ:TMDX)August 1 at 6:53 AM | marketbeat.comTransMedics (TMDX) Q2 Revenue Jumps 38%July 31 at 5:16 AM | fool.comTransMedics Group, Inc. (TMDX) Q2 2025 Earnings Call TranscriptJuly 31 at 2:11 AM | seekingalpha.comTransMedics (TMDX) Reports Q2 Earnings: What Key Metrics Have to SayJuly 30 at 8:01 PM | zacks.comTransMedics shares soar as Q2 earnings double analyst estimatesJuly 30 at 7:08 PM | za.investing.comTransMedics (TMDX) Q2 Earnings and Revenues Surpass EstimatesJuly 30 at 7:06 PM | zacks.comTransMedics Sees Its Earnings SoarJuly 30 at 5:39 PM | fool.comTransMedics Reports Second Quarter 2025 Financial ResultsJuly 30 at 4:05 PM | prnewswire.comLive Earnings: Will TransMedics (TMDX) Rally After Earnings?July 30 at 12:20 PM | 247wallst.comTransMedics to Present at the Canaccord Genuity 45th Annual Growth ConferenceJuly 29, 2025 | prnewswire.comTransMedics Group Sees IBD RS Rating Climb To 74July 29, 2025 | msn.comTransMedics Group (TMDX) Expected to Announce Earnings on WednesdayJuly 29, 2025 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonAmerica Wants Drone Dominance: Are These Stocks Ready to Soar?By Chris Markoch | July 20, 2025View America Wants Drone Dominance: Are These Stocks Ready to Soar?Super Micro Computer Sees Unusual Volume—Catalyst Ahead?By Gabriel Osorio-Mazilli | July 25, 2025View Super Micro Computer Sees Unusual Volume—Catalyst Ahead?Why Wall Street Is Betting on These 3 Comeback StocksBy Nathan Reiff | July 12, 2025View Why Wall Street Is Betting on These 3 Comeback StocksTMDX, EE, and ECG Company DescriptionsEverus Construction Group NYSE:ECG$70.14 -4.12 (-5.55%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$70.22 +0.08 (+0.11%) As of 08/1/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers. Everus Construction Group is based in BISMARCK, N.D.Excelerate Energy NYSE:EE$25.55 -0.11 (-0.43%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$25.56 +0.01 (+0.04%) As of 08/1/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Excelerate Energy, Inc. provides flexible liquefied natural gas (LNG) solutions worldwide. The company offers regasification services, including floating storage and regasification units (FSRUs), infrastructure development, and LNG and natural gas supply, procurement, and distribution services; LNG terminal services; and natural gas supply to-power projects. Excelerate Energy, Inc. was founded in 2003 and is headquartered in The Woodlands, Texas. Excelerate Energy, Inc. is a subsidiary of Excelerate Energy Holdings, LLC.TransMedics Group NASDAQ:TMDX$120.55 +1.58 (+1.33%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$121.16 +0.62 (+0.51%) As of 08/1/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
